ES2166988T3 - Terapia de administracion uniforme de farmacos. - Google Patents

Terapia de administracion uniforme de farmacos.

Info

Publication number
ES2166988T3
ES2166988T3 ES97916120T ES97916120T ES2166988T3 ES 2166988 T3 ES2166988 T3 ES 2166988T3 ES 97916120 T ES97916120 T ES 97916120T ES 97916120 T ES97916120 T ES 97916120T ES 2166988 T3 ES2166988 T3 ES 2166988T3
Authority
ES
Spain
Prior art keywords
pharmacos
administration therapy
uniform administration
uniform
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97916120T
Other languages
English (en)
Inventor
Atul Devdatt Ayer
Andrew Lam
Judy A Magruder
Lawrence G Hamel
Patrick S-L Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ES2166988T3 publication Critical patent/ES2166988T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCION EXPUESTA SE REFIERE A UN NUEVO SISTEMA DE ADMINISTRACION QUE COMPRENDE UNA FORMULACION DE AGENTES Y MEDIOS PARA DISTRIBUIR LA FORMULACION DE AGENTES A PARTIR DEL SISTEMA DE ADMINISTRACION.
ES97916120T 1996-04-05 1997-03-20 Terapia de administracion uniforme de farmacos. Expired - Lifetime ES2166988T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1488996P 1996-04-05 1996-04-05

Publications (1)

Publication Number Publication Date
ES2166988T3 true ES2166988T3 (es) 2002-05-01

Family

ID=21768382

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97916120T Expired - Lifetime ES2166988T3 (es) 1996-04-05 1997-03-20 Terapia de administracion uniforme de farmacos.

Country Status (14)

Country Link
EP (1) EP0907358B1 (es)
JP (1) JP4262776B2 (es)
AR (1) AR006087A1 (es)
AT (1) ATE210429T1 (es)
AU (1) AU710389B2 (es)
BR (1) BR9708528A (es)
DE (1) DE69709101T2 (es)
DK (1) DK0907358T3 (es)
ES (1) ES2166988T3 (es)
HK (1) HK1020523A1 (es)
NZ (1) NZ332014A (es)
PT (1) PT907358E (es)
WO (1) WO1997037640A2 (es)
ZA (1) ZA97976B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274171B1 (en) 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
BR9810403A (pt) * 1997-07-01 2000-08-29 Pfizer Sais da sertralina e formas de dosagem de liberação sustentada da sertralina
TR199903297T2 (xx) * 1997-07-01 2000-07-21 Pfizer Products Inc. ��z�lm�� sertralin bile�imleri.
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
KR100827254B1 (ko) * 1998-06-03 2008-05-07 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치
RU2246295C2 (ru) * 1998-11-02 2005-02-20 Элзэ Копэрейшн Лекарственная форма c постоянной скоростью высвобождения лекарственного вещества, ядро лекарственной формы и способ обеспечения облегченного высвобождения лекарственного вещества из лекарственной формы
AU1789301A (en) * 1999-11-22 2001-06-04 Alza Corporation Osmotic dosage form comprising first and second
EP1239839A2 (en) 1999-12-23 2002-09-18 Pfizer Products Inc. Hydrogel-driven layered drug dosage form comprising sertraline
ATE404140T1 (de) 2000-08-30 2008-08-15 Univ Johns Hopkins Vorrichtung zur intraokularen wirkstoffverabreichung
CA2450001A1 (en) * 2001-06-21 2003-01-03 Andrx Pharmaceuticals, Inc. Stable pharmaceutical compositions containing pravastatin
DE10149674A1 (de) 2001-10-09 2003-04-24 Apogepha Arzneimittel Gmbh Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
GB2392385A (en) * 2002-09-02 2004-03-03 Cipla Ltd Pharmaceutical preparations comprising a 5HT uptake inhibitor and a homopolymer or copolymer of N-vinyl pyrrolidone
KR100795419B1 (ko) * 2006-01-03 2008-01-17 (주)네오메딕스 암로디핀 및 아스피린을 함유하는 약학 제제
US8747897B2 (en) * 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
US9827401B2 (en) 2012-06-01 2017-11-28 Surmodics, Inc. Apparatus and methods for coating medical devices
US9308355B2 (en) 2012-06-01 2016-04-12 Surmodies, Inc. Apparatus and methods for coating medical devices
EP3878445A3 (en) 2013-06-05 2021-10-27 Synchroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2020112816A1 (en) 2018-11-29 2020-06-04 Surmodics, Inc. Apparatus and methods for coating medical devices
US11819590B2 (en) 2019-05-13 2023-11-21 Surmodics, Inc. Apparatus and methods for coating medical devices
WO2023145120A1 (ja) * 2022-01-31 2023-08-03 住友精化株式会社 薬物放出制御製剤用組成物及び薬物放出制御製剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1503116A (en) * 1975-07-28 1978-03-08 Alza Corp Sustained release drug delivery devices
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug

Also Published As

Publication number Publication date
ATE210429T1 (de) 2001-12-15
AU710389B2 (en) 1999-09-16
JP4262776B2 (ja) 2009-05-13
PT907358E (pt) 2002-05-31
WO1997037640A3 (en) 1997-11-13
NZ332014A (en) 1999-04-29
DE69709101T2 (de) 2002-04-25
BR9708528A (pt) 1999-08-03
ZA97976B (en) 1997-08-18
HK1020523A1 (en) 2000-05-12
DE69709101D1 (de) 2002-01-24
JP2000508313A (ja) 2000-07-04
AU2337897A (en) 1997-10-29
EP0907358A2 (en) 1999-04-14
EP0907358B1 (en) 2001-12-12
DK0907358T3 (da) 2002-03-25
AR006087A1 (es) 1999-08-11
WO1997037640A2 (en) 1997-10-16

Similar Documents

Publication Publication Date Title
ES2166988T3 (es) Terapia de administracion uniforme de farmacos.
BR0112054A (pt) Composição formadora de micelas, e métodos para a administração e a proteção de um agente terapêutico
ES2163035T3 (es) Sistema transcorneo para la liberacion de medicamentos.
MA26456A1 (fr) Formulations pharmaceutiques pour la distribution prolongee de medicament.
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
BR9808703A (pt) Composição que fornece medicamento solúvel emágua de dissolução relativamente lenta e usosublingual
NO20063853L (no) Kombinasjonsterapi for osteoporose
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
ATE417604T1 (de) Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe
GT199800136A (es) Formas de dosificacion farmaceuticas solidas.
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
ES2172239T3 (es) Sistema osmotico de liberacion de farmacos.
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
ATE234274T1 (de) Derivate des adamantan
PA8435001A1 (es) Derivados 6,6-heterobiciclicos sustituidos.
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
CY1105465T1 (el) Μορφη δοσολογιας πepιλαμβανουσα υγρο σκευασμα
SE9604751D0 (sv) New therapy
NO20022525D0 (no) Farmasöytiske formuleringer inneholdende zolmitriptan
DE59408643D1 (de) Transdermale therapeutische systeme zur verabreichung von serotoninagonisten
BR9608255A (pt) Sistema terapéutico transdérmico (stt) para a administração de testosterona
ATE275966T1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
ATE353224T1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
AR017664A1 (es) Formulaciones farmaceuticas de liberacion sostenida que contienen inhibidores de la alfa-glucosidasa y su uso para la manufactura de un medicamento
ES2184987T3 (es) Formas de administracion solidas de liberacion instantanea y procedimiento para su preparacion.